Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company specializing in therapies for central nervous system disorders and rare diseases, has unveiled
Read more
The Biosimilar Tyruko® has been approved for all indications of reference medicine, as the first and only biosimilar to treat
Read more
StressMarq manufactures and offers a comprehensive range of Alzheimer’s Disease Research Products. StressMarq’s product range includes Antibodies, Proteins, Immunoassays, Small
Read more
The Synuclein-α (Phospho-Ser129) Colorimetric Cell-Based ELISA Kit is a user-friendly and highly sensitive assay designed to detect the protein expression
Read more
StressMarq provides a cutting-edge selection of Amyloid Beta Pre-formed Fibrils (PFFs), Oligomers, and Monomers specifically designed to facilitate advanced neurodegenerative
Read more
StressMarq has developed unique Superoxide Dismutase 1 (SOD1) Pre-formed Fibrils (PFFs) and monomers for neurodegenerative disease research, particularly valuable for
Read more
StressMarq has developed unique Transthyretin (TTR) Filaments and Monomers designed to propel research on TTR and its association with amyloid
Read more
StressMarq has developed unique alpha synuclein constructs to provide invaluable support to researchers engaged in disease model development and the
Read more
StressMarq is a pioneer in the development of tau proteins that facilitate the investigation of tau aggregation, a key characteristic
Read more
Parkinson’s Disease is characterized by the aggregation of alpha-synuclein, a key pathological feature. In this informative video, the mechanism underlying
Read more